Literature DB >> 1941824

The role of antineutrophil cytoplasm antibodies, anticardiolipin antibodies, von Willebrand factor antigen, and fibronectin for the diagnosis of systemic vasculitis.

L Bleil1, B Manger, T H Winkler, M Herrman, G R Burmester, F E Krapf, J R Kalden.   

Abstract

Autoantibodies directed against cytoplasmic components of neutrophil granulocytes and monocytes (c-ANCA) are a disease specific marker for Wegner's granulomatosis (WG). Autoantibodies against cardiolipin (aCl) are specific for a subgroup of autoimmune disorders, which can also be associated with systemic vasculitis. Fibronectin (Fn) and von Willebrand factor antigen (vWfAg) are produced by blood vessel endothelial cells in response to injury. We tested sera of 61 patients with various types of systemic vasculitides, sera of 13 patients with retinal vasculitis, and sera of 199 patients with rheumatic diseases for c-ANCA, aCl, Fn, and vWfAg. c-ANCA was positive in 14/17 patients with WG, and 2/4 with polyarteritis nodosa (PAN). No serum from healthy donors or patients with other vasculitic or rheumatic diseases was positive for c-ANCA. Moreover, we found aCl, Fn, and vWfAg significantly elevated in almost all patients with vasculitic syndromes. Therefore, we consider c-ANCA a marker, specific for the diagnosis of WG or PAN, whereas aCl, Fn, and vWfAg are nonspecific but sensitive markers of vascular damage.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1941824

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

Review 1.  Role of proteinase 3 in activation of endothelium.

Authors:  M E Taekema-Roelvink; C van Kooten; C A Verburgh; M R Daha
Journal:  Springer Semin Immunopathol       Date:  2001

2.  Polyarteritis nodosa and the antiphospholipid syndrome.

Authors:  R Schoonjans; B Van Vlem; S Weyers; F De Keyser; M Praet; J Versieck; A Elewaut
Journal:  Clin Rheumatol       Date:  1996-07       Impact factor: 2.980

Review 3.  Assessment of disease activity in systemic vasculitis.

Authors:  W Y Tse; P Cockwell; C O Savage
Journal:  Postgrad Med J       Date:  1998-01       Impact factor: 2.401

4.  Fibronectin and circulating immune complexes in Behet's disease.

Authors:  K Ozoran; N Düzgün; H Tutkak; A Gürler; G Tokgöz
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

5.  Soluble intercellular adhesion molecule-1 (sICAM-1) as a marker of disease relapse in idiopathic uveoretinitis.

Authors:  A G Zaman; C Edelsten; M R Stanford; E M Graham; B A Ellis; H Direskeneli; D P D'Cruz; G R Hughes; D C Dumonde; G R Wallace
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

6.  Tissue plasminogen activator, plasminogen activator inhibitor-1 and von Willebrand factor in rheumatoid arthritis.

Authors:  S Wållberg-Jonsson; G H Dahlén; T K Nilsson; M Rånby; S Rantapää-Dahlqvist
Journal:  Clin Rheumatol       Date:  1993-09       Impact factor: 2.980

Review 7.  ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.

Authors:  W L Gross; W H Schmitt; E Csernok
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

8.  Myositis, Vasculitis, Hepatic Dysfunction in Adult-Onset Still's Disease.

Authors:  Hidekatsu Yanai; Nobuyuki Furutani; Hiroshi Yoshida; Norio Tada
Journal:  Case Rep Med       Date:  2009-06-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.